พอดคาสต์นี้อาจไม่ออกตอนใหม่อีกต่อไปและไฟล์เสียงบางส่วนอาจเสีย
Maybe this podcast has a new rss feed?
เกี่ยวกับพอดแคสต์นี้ 🔗
Clarivate Analytics Oncology Talks provides expert insights on key issues and trends in the areas of oncology research.
ความถี่ในการอัพเดต:
every 18 days
ความยาวเสียงโดยเฉลี่ย:
11 minutes
ภาษาอังกฤษ
ประเทศอังกฤษ
8 ตอน
ตั้งแต่ 3 พฤศจิกายน 2016
episodic
ตอนล่าสุด 🔗
Immuno-oncology therapies have opened up the most promising frontiers in cancer treatment today. But, with drug development costs increasing, how is it possible to maintain commercial viability?
Peter Winter, Editor at BioWorld, talks about challenges to commercial viability in the immuno-oncolog…
ตอนก่อนหน้านี้ 🔗
Cancer immunotherapy research continues to evolve and offers patients a transformative alternative to traditional therapies. Anette Briendl, Senior Science Editor at BioWorld, talks about the current research landscape for immunotherapies. Learn about the challenges and potential of emerging therap…
The recent buzz around CRISPR-Cas9, a genome editing tool, has revolved around its potential for treating various genetic diseases, including cancer. Jack Hopwood, Intellectual Property Consultant and Bertrand Sautier, Strategic Account Manager at Clarivate Analytics talk about how research activit…
Recently, the U.S. Patent and Trademark Office’s released a dataset that contained over 250,000 records, included patent applications and granted patents; the USPTO was interested in the insights this data could reveal to guide cancer research. Di Cross, Director of Research at Clarivate Anal…
Join Chris Willis, Manager of Discovery and Translational Sciences at Clarivate Analytics, as he talks about immuno-oncology, why it is promising for cancer patients and how it continues to evolve. Learn more about the new approved drugs on the market that treat indications of cancer and the way in…
The Cancer Moonshot Initiative is intended to accelerate the pace of cancer research. The field of cancer immunotherapy presents real promise for cancer patients – offering a less toxic treatment protocol that reduces their suffering. Amy Braden, a Solutions Specialist at Clarivate Analytics, provi…
Historically, clinicians have fought cancer with tools such as radiation, surgery and chemotherapy, which kill cancerous cells, but also damage healthy cells or nearby tissues. Immuno-oncology presents a whole new treatment paradigm; it tunes the immune system to specifically fight cancer cells wit…
คุณดูทุกตอนในพอดแคสต์นี้แล้ว
ข้อสงวนสิทธิ์: พอดแคสต์และอาร์ตเวิร์คที่ฝังอยู่ในหน้านี้มาจาก Clarivate Analytics – Formerly the IP&Science business of Thomson Reuters ซึ่งเป็นทรัพย์สินของเจ้าของและไม่มีส่วนเกี่ยวข้องหรือรับรองโดย Listen Notes, Inc.
เครื่องมือค้นหาพอดแคสต์
คุณสามารถใช้เว็บไซต์ของเราเพื่อค้นหาพอดแคสต์ของ3,828,256และตอนของ196,425,526ตามบุคคล สถานที่ หรือหัวข้อ
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
อ้างสิทธิ์ในพอดแคสต์นี้
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post โฆษณาย่อย for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
บทสัมภาษณ์ผู้จัดทำพอดแคสต์...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
บัญชี X อย่างเป็นทางการของเรา (เดิมคือ Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
